1. Nebulised amiloride in respiratory exacerbations of cystic fibrosis: a randomised controlled trial;Bowler, I.M.; Kellerman, B.; Worthington, D.; Littlewood, J.M.; Watson, A.; Conway, S.P.;Arch Dis Child,1995
2. No added benefit from nebulised amiloride in patients with cystic fibrosis;Graham, A.; Hasani, A.; Alton, E.W.F.W.; Martin, G.P.; Marriott, C.; Hodson, M.E.,1993
3. Loperamide inhibits the enhanced intestinal glucose absorption in cystic fibrosis;Hardcastle, J.; Hardcastle, P.T.; Taylor, C.J.;Pediatr Res,1994
4. Nasal potential difference: a clinical diagnostic test for cystic fibrosis;Alton, E.W.; Currie, D.; Logan-Sinclair, R.; Warner, J.O.; Hodson, M.E.; Geddes, D.M.;Eur Respir J
5. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis;Knowles, M.R.; Gatzy, J.; Boucher, R.;N Engl J Med,1981